StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

CRNXBullishM&Anews
High materiality9/10

Vertex to acquire Crinetics for $85 per share in cash; CRNX surges

Jul 6, 2026, 4:51 PM EDT3 sourcesAI-analyzed
Why it may matterVerify against the original reporting

The cash offer establishes an explicit value floor near $85, triggering a strong immediate uptick in CRNX. Historical takeovers show target stocks often move toward the offer price, though closing risk remains if regulatory or financing issues arise.

AI summary

What happened, with direct paths to the underlying reporting

Vertex has agreed to acquire Crinetics for $85 per share in cash, valuing the company at about $10 billion. The deal, unanimously approved by boards, is expected to close in Q3. Crinetics' stock jumped more than 100% in after-hours trading to roughly $84.70, signaling strong near-term investor acceptance but leaving execution risk until closing.

  • Vertex to buy Crinetics for $85 per share in cash.
  • Equity value around $10B; closing expected in Q3.
  • Crinetics shares up ~101% after-hours; price near $84.69.
  • Transaction unanimously approved by boards.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.